Natural insecticide developer has won $3 million of US military grants to tackle the problems of mosquito-borne diseases, ticks and bed bugs. ASX biotechs bolster their US manufacturing footprint ...

Natural insecticide developer has won $3 million of US military grants to tackle the problems of mosquito-borne diseases, ticks and bed bugs. Don't miss out on the headlines from Stockhead.

IDEXX’s IDXX business continues to be dampened by currency impacts and uncertain macroeconomic conditions. The stock carries a Zacks Rank #4 (Sell) currently. In recent times, U.S. clinical ...

Leerink Partners analyst Daniel Clark maintained a Buy rating on Idexx Laboratories (IDXX – Research Report) on January 26 and set a price target of $500.00. Daniel Clark has given his Buy ...